What is it about?
What is already known on this subject? In Spain, the selection of medicines and health products, that must be evaluated prior to their incorporation into the Hospital Pharmacy practice, is done according to the basic criteria included in the regulations, but currently there is no explicit evaluation procedure. The present review has the purpose of identifying criteria, processes and conceptual frameworks that can serve as a basis for its development.
Featured Image
Why is it important?
What this study adds? A comprehensive review of the criteria and considerations for the selection of health priorities, is presented, and a detailed summary of the procedures used by the international evaluation agencies. A critical analysis, of all the aspects that may be important and recommendations are offered that could be useful both at the national level and for any public body that intends to establish priorities in health.
Perspectives
This research was presented, in part, as an abstract and a poster at the 2018 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium (VPS), May 16–24, 2018. Poster number 186, presented on Thursday, May 24th, 2018 from 7:00 p.m. to 9:00 p.m. (EDT). For the revised manuscript, we will take into account VPS reviewers' scores and comments.
Dr Alberto Frutos Pérez-Surio
Hospital Clinico Universitario Lozano Blesa
Read the Original
This page is a summary of: 2018 ACCP Virtual Poster Symposium, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2018, Wiley,
DOI: 10.1002/phar.2144.
You can read the full text:
Contributors
The following have contributed to this page
